Anil K. Agarwal, MD NASHVILLE—Researchers who analyzed data from clinical trials of darbepoetin alfa in anemic non-dialysis CKD patients found that all patients experience variable hemoglobin (Hb) ...
Maintaining hemoglobin levels within the recommended target range in patients on dialysis may reduce economic burden. Increasing and maintaining mean hemoglobin levels to within the target range is ...
LOS ANGELES (Reuters) - The National Kidney Foundation said on Thursday it plans to cut its recommended target for hemoglobin levels in kidney disease patients -- a move that could hurt sales of ...
Philadelphia, PA - Successive increases in average erythropoietin (EPO) doses to alleviate anemia in end-stage renal-disease (ESRD) patients have occurred over the past 14 years in parallel with ...
Please provide your email address to receive an email when new articles are posted on . For 40% of observations, the monthly hemoglobin concentration was less than 10 ...
Non–placebo-controlled trials of erythropoiesis-stimulating agents (ESAs) comparing lower and higher hemoglobin targets in patients with chronic kidney disease indicate that targeting of a lower ...
LOS ANGELES, April 12 (Reuters) - A panel of U.S. kidney disease experts on Thursday called for less-aggressive treatment of kidney disease patients -- a move that could hurt sales of lucrative anemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results